[Toxicity and antineoplastic activity of some ethers of phosphoric and phosphinic acid].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002066:Busulfan / Q000627:therapeutic use / Q000633:toxicity*; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D004987:Ethers / Q000627:therapeutic use / Q000633:toxicity*; D005019:Ethyl Ethers / Q000627:therapeutic use / Q000633:toxicity; D007970:Leukopenia / Q000139:chemically induced; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D010721:Phosphinic Acids / Q000627:therapeutic use / Q000633:toxicity*; D010756:Phosphoric Acids / Q000627:therapeutic use / Q000633:toxicity*; D051381:Rats; D012509:Sarcoma / Q000188:drug therapy; D012510:Sarcoma 180 / Q000188:drug therapy; D012511:Sarcoma 37 / Q000188:drug therapy
D000970:Antineoplastic Agents; D004987:Ethers; D005019:Ethyl Ethers; D010721:Phosphinic Acids; D010756:Phosphoric Acids; D002066:Busulfan
Toksichnost' i protivoopuk holevaia aktivnost' nekotorykh éfirov fosfornoĭ i fosfinovoĭ kislot.